<s id="wsj_1597.1"> 27
2 	 0 	 N/N 	 1 	 Co. Colgate
2 	 1 	 N/N 	 1 	 Co. Palmolive
2 	 3 	 (S[dcl]\NP)/S[dcl] 	 1 	 Co. reported
6 	 4 	 N/N 	 1 	 income third-quarter
6 	 5 	 N/N 	 1 	 income net
6 	 7 	 S[dcl]\NP 	 1 	 income rose
6 	 11 	 S[pss]\NP 	 1 	 income bolstered <XB>
7 	 3 	 (S[dcl]\NP)/S[dcl] 	 2 	 rose reported
7 	 9 	 (S\NP)\(S\NP) 	 2 	 rose %
9 	 8 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 27
11 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 bolstered by
14 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 sales by
14 	 13 	 N/N 	 1 	 sales strong
14 	 15 	 (NP\NP)/NP 	 1 	 sales in
18 	 17 	 (N/N)/(N/N) 	 2 	 American Latin
19 	 15 	 (NP\NP)/NP 	 2 	 business in
19 	 16 	 NP[nb]/N 	 1 	 business its
19 	 18 	 N/N 	 1 	 business American
22 	 21 	 (N/N)/(N/N) 	 2 	 healthy surprisingly
23 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 profits by
23 	 22 	 N/N 	 1 	 profits healthy
23 	 24 	 (NP\NP)/NP 	 1 	 profits from
26 	 24 	 (NP\NP)/NP 	 2 	 operations from
26 	 25 	 N/N 	 1 	 operations U.S.
<\s>
<s id="wsj_1597.2"> 29
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 Colgate said
3 	 2 	 N/N 	 1 	 income net
3 	 4 	 (NP\NP)/NP 	 1 	 income for
3 	 7 	 S[dcl]\NP 	 1 	 income rose
6 	 4 	 (NP\NP)/NP 	 2 	 quarter for
6 	 5 	 NP[nb]/N 	 1 	 quarter the
7 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 rose said
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 rose to
7 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 rose on
9 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
11 	 9 	 N/N[num] 	 1 	 million $
11 	 10 	 N/N 	 1 	 million 76.7
14 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
14 	 16 	 (NP\NP)/N 	 1 	 $ a
15 	 14 	 N/N[num] 	 1 	 1.06 $
17 	 16 	 (NP\NP)/N 	 2 	 share a
20 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 sales on
20 	 21 	 (NP\NP)/(S[dcl]\NP) 	 1 	 sales that
20 	 22 	 S[dcl]\NP 	 1 	 sales increased <XB>
22 	 21 	 (NP\NP)/(S[dcl]\NP) 	 2 	 increased that
22 	 24 	 (S\NP)\(S\NP) 	 2 	 increased %
22 	 25 	 ((S\NP)\(S\NP))/NP 	 2 	 increased to
24 	 23 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 6
26 	 25 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
28 	 26 	 N/N[num] 	 1 	 billion $
28 	 27 	 N/N 	 1 	 billion 1.3
<\s>
<s id="wsj_1597.3"> 19
3 	 0 	 (S/S)/NP 	 2 	 period In
3 	 1 	 NP[nb]/N 	 1 	 period the
3 	 2 	 N/N 	 1 	 period year-earlier
5 	 6 	 (S[dcl]\NP)/NP 	 1 	 Colgate posted
6 	 0 	 (S/S)/NP 	 1 	 posted In
8 	 6 	 (S[dcl]\NP)/NP 	 2 	 income posted
8 	 7 	 N/N 	 1 	 income net
8 	 9 	 (NP\NP)/NP 	 1 	 income of
10 	 9 	 (NP\NP)/NP 	 2 	 $ of
12 	 10 	 N/N[num] 	 1 	 million $
12 	 11 	 N/N 	 1 	 million 60.2
16 	 9 	 (NP\NP)/NP 	 2 	 cents of
16 	 15 	 N/N 	 1 	 cents 88
16 	 17 	 (NP\NP)/N 	 1 	 cents a
18 	 17 	 (NP\NP)/N 	 2 	 share a
<\s>
<s id="wsj_1597.4"> 19
1 	 0 	 N/N 	 1 	 year Last
1 	 2 	 (NP[nb]/N)\NP 	 2 	 year 's
3 	 2 	 (NP[nb]/N)\NP 	 1 	 results 's
3 	 4 	 (S[dcl]\NP)/NP 	 1 	 results included
5 	 4 	 (S[dcl]\NP)/NP 	 2 	 earnings included
5 	 6 	 (NP\NP)/NP 	 1 	 earnings from
5 	 9 	 (NP\NP)/NP 	 1 	 earnings of
8 	 6 	 (NP\NP)/NP 	 2 	 operations from
8 	 7 	 N/N 	 1 	 operations discontinued
10 	 9 	 (NP\NP)/NP 	 2 	 $ of
12 	 10 	 N/N[num] 	 1 	 million $
12 	 11 	 N/N 	 1 	 million 13.1
16 	 9 	 (NP\NP)/NP 	 2 	 cents of
16 	 15 	 N/N 	 1 	 cents 19
16 	 17 	 (NP\NP)/N 	 1 	 cents a
18 	 17 	 (NP\NP)/N 	 2 	 share a
<\s>
<s id="wsj_1597.5"> 28
1 	 0 	 N/N 	 1 	 Mark Reuben
1 	 11 	 (S[dcl]\NP)/S[dcl] 	 1 	 Mark said
3 	 8 	 (NP\NP)/NP 	 1 	 chairman of
3 	 11 	 (S[dcl]\NP)/S[dcl] 	 1 	 chairman said
7 	 5 	 N/N 	 1 	 officer chief
7 	 6 	 N/N 	 1 	 officer executive
7 	 8 	 (NP\NP)/NP 	 1 	 officer of
7 	 11 	 (S[dcl]\NP)/S[dcl] 	 1 	 officer said
9 	 8 	 (NP\NP)/NP 	 2 	 Colgate of
13 	 12 	 N/N 	 1 	 growth earnings
13 	 14 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 growth was
13 	 15 	 S[pss]\NP 	 1 	 growth fueled <XB>
14 	 11 	 (S[dcl]\NP)/S[dcl] 	 2 	 was said
15 	 14 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 fueled was
15 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 fueled by
18 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 sales by
18 	 17 	 N/N 	 1 	 sales strong
18 	 19 	 (NP\NP)/NP 	 1 	 sales in
21 	 19 	 (NP\NP)/NP 	 2 	 America in
21 	 20 	 N/N 	 1 	 America Latin
25 	 19 	 (NP\NP)/NP 	 2 	 East in
25 	 23 	 NP[nb]/N 	 1 	 East the
25 	 24 	 N/N 	 1 	 East Far
27 	 19 	 (NP\NP)/NP 	 2 	 Europe in
<\s>
<s id="wsj_1597.6"> 20
0 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 Results were
0 	 3 	 S[pss]\NP 	 1 	 Results bolstered <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 were also
1 	 19 	 (S[dcl]\S[dcl])\NP 	 1 	 were said
3 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 bolstered were
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 bolstered by
7 	 6 	 (N/N)/(N/N) 	 2 	 meaningful very
8 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 increase by
8 	 5 	 NP[nb]/N 	 1 	 increase a
8 	 7 	 N/N 	 1 	 increase meaningful
8 	 9 	 (NP\NP)/NP 	 1 	 increase in
8 	 12 	 (NP\NP)/NP 	 1 	 increase at
11 	 9 	 (NP\NP)/NP 	 2 	 profit in
11 	 10 	 N/N 	 1 	 profit operating
13 	 14 	 (NP[nb]/N)\NP 	 2 	 Colgate 's
16 	 12 	 (NP\NP)/NP 	 2 	 business at
16 	 14 	 (NP[nb]/N)\NP 	 1 	 business 's
16 	 15 	 N/N 	 1 	 business U.S.
18 	 19 	 (S[dcl]\S[dcl])\NP 	 2 	 he said
<\s>
<s id="wsj_1597.7"> 35
1 	 0 	 N/N 	 1 	 profit Operating
1 	 2 	 (NP\NP)/NP 	 1 	 profit at
1 	 26 	 S[dcl]\NP 	 1 	 profit jumped
3 	 4 	 (NP[nb]/N)\NP 	 2 	 Colgate 's
11 	 2 	 (NP\NP)/NP 	 2 	 businesses at
11 	 4 	 (NP[nb]/N)\NP 	 1 	 businesses 's
11 	 5 	 N/N 	 1 	 businesses U.S.
11 	 6 	 N/N 	 1 	 businesses household
11 	 7 	 N/N 	 1 	 businesses products
11 	 9 	 N/N 	 1 	 businesses personal
11 	 10 	 N/N 	 1 	 businesses care
11 	 13 	 (NP\NP)/(S[dcl]\NP) 	 1 	 businesses which
11 	 14 	 (S[dcl]\NP)/NP 	 1 	 businesses include <XB>
14 	 13 	 (NP\NP)/(S[dcl]\NP) 	 2 	 include which
17 	 14 	 (S[dcl]\NP)/NP 	 2 	 brands include
17 	 15 	 NP/NP 	 1 	 brands such
17 	 16 	 N/N 	 1 	 brands well-known
17 	 18 	 (NP\NP)/NP 	 1 	 brands as
20 	 18 	 (NP\NP)/NP 	 2 	 toothpaste as
20 	 19 	 N/N 	 1 	 toothpaste Colgate
24 	 18 	 (NP\NP)/NP 	 2 	 detergent as
24 	 22 	 N/N 	 1 	 detergent Fab
24 	 23 	 N/N 	 1 	 detergent laundry
26 	 30 	 (S\NP)\(S\NP) 	 2 	 jumped %
26 	 34 	 (S[dcl]\S[dcl])\NP 	 1 	 jumped said
27 	 28 	 ((((S\NP)\(S\NP))/((S\NP)\(S\NP)))/(((S\NP)\(S\NP))/((S\NP)\(S\NP))))\(S[adj]\NP) 	 5 	 more than
29 	 28 	 ((((S\NP)\(S\NP))/((S\NP)\(S\NP)))/(((S\NP)\(S\NP))/((S\NP)\(S\NP))))\(S[adj]\NP) 	 4 	 40 than
30 	 29 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 40
33 	 32 	 NP[nb]/N 	 1 	 company the
33 	 34 	 (S[dcl]\S[dcl])\NP 	 2 	 company said
<\s>
<s id="wsj_1597.8"> 28
1 	 0 	 N/N 	 1 	 Mark Mr.
1 	 2 	 ((S[dcl]\NP)/PP)/NP 	 1 	 Mark attributed
4 	 2 	 ((S[dcl]\NP)/PP)/NP 	 3 	 improvement attributed
4 	 3 	 NP[nb]/N 	 1 	 improvement the
5 	 2 	 ((S[dcl]\NP)/PP)/NP 	 2 	 to attributed
7 	 5 	 PP/NP 	 1 	 savings to
7 	 6 	 N/N 	 1 	 savings cost
7 	 8 	 S[pss]\NP 	 1 	 savings achieved <XB>
7 	 10 	 (S[ng]\NP)/NP 	 1 	 savings consolidating <XB>
7 	 14 	 ((S[ng]\NP)/NP)/(S[adj]\NP) 	 1 	 savings blending <XU>
7 	 22 	 (S[ng]\NP)/NP 	 1 	 savings focusing <XU>
8 	 9 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 achieved by
10 	 9 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 consolidating by
12 	 10 	 (S[ng]\NP)/NP 	 2 	 operations consolidating
12 	 11 	 N/N 	 1 	 operations manufacturing
14 	 9 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 blending by
15 	 14 	 ((S[ng]\NP)/NP)/(S[adj]\NP) 	 3 	 together blending
18 	 14 	 ((S[ng]\NP)/NP)/(S[adj]\NP) 	 2 	 organizations blending
18 	 15 	 S[adj]\NP 	 1 	 organizations together <XB>
18 	 16 	 N/N 	 1 	 organizations two
18 	 17 	 N/N 	 1 	 organizations sales
21 	 20 	 ((S\NP)/(S\NP))/((S\NP)/(S\NP)) 	 3 	 carefully more
22 	 9 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 focusing by
22 	 21 	 (S\NP)/(S\NP) 	 2 	 focusing carefully
24 	 23 	 NP[nb]/N 	 1 	 company the
24 	 25 	 (NP[nb]/N)\NP 	 2 	 company 's
27 	 22 	 (S[ng]\NP)/NP 	 2 	 activities focusing
27 	 25 	 (NP[nb]/N)\NP 	 1 	 activities 's
27 	 26 	 N/N 	 1 	 activities promotional
<\s>
<s id="wsj_1597.9"> 23
0 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 We 've
0 	 2 	 (S[pt]\NP)/NP 	 1 	 We done <XB>
0 	 6 	 (S[b]\NP)/NP 	 1 	 We improve <XB>
1 	 22 	 (S[dcl]\S[dcl])\NP 	 1 	 've said
2 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 done 've
4 	 2 	 (S[pt]\NP)/NP 	 2 	 lot done
4 	 3 	 NP[nb]/N 	 1 	 lot a
6 	 5 	 (S[to]\NP)/(S[b]\NP) 	 2 	 improve to
8 	 7 	 (N/N)/N 	 2 	 U.S. -LRB-
11 	 6 	 (S[b]\NP)/NP 	 2 	 results improve
11 	 7 	 (N/N)/N 	 1 	 results -LRB-
15 	 13 	 NP[nb]/N 	 1 	 more a
15 	 14 	 N/N 	 1 	 more lot
15 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 more will
15 	 18 	 S[pss]\NP 	 1 	 more done <XB>
16 	 22 	 (S[dcl]\S[dcl])\NP 	 1 	 will said
17 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
18 	 17 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 done be
21 	 20 	 N/N 	 1 	 Mark Mr.
21 	 22 	 (S[dcl]\S[dcl])\NP 	 2 	 Mark said
<\s>
<s id="wsj_1597.10"> 13
1 	 0 	 N/N 	 1 	 profitability Improving
1 	 2 	 (NP\NP)/NP 	 1 	 profitability of
1 	 5 	 (S[dcl]\NP)/NP 	 1 	 profitability is
4 	 2 	 (NP\NP)/NP 	 2 	 operations of
4 	 3 	 N/N 	 1 	 operations U.S.
5 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 is in
8 	 7 	 (N/N)/(N/N) 	 2 	 high extremely
9 	 5 	 (S[dcl]\NP)/NP 	 2 	 priority is
9 	 6 	 NP[nb]/N 	 1 	 priority an
9 	 8 	 N/N 	 1 	 priority high
12 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 company in
12 	 11 	 NP[nb]/N 	 1 	 company the
<\s>
<s id="wsj_1597.11"> 15
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Colgate 's
2 	 1 	 (NP[nb]/N)\NP 	 1 	 results 's
2 	 3 	 (S[dcl]\NP)/PP 	 1 	 results were
4 	 3 	 (S[dcl]\NP)/PP 	 2 	 at were
7 	 4 	 PP/NP 	 1 	 end at
7 	 5 	 NP[nb]/N 	 1 	 end the
7 	 6 	 N/N 	 1 	 end high
7 	 8 	 (NP\NP)/NP 	 1 	 end of
10 	 8 	 (NP\NP)/NP 	 2 	 range of
10 	 9 	 NP[nb]/N 	 1 	 range the
10 	 11 	 (NP\NP)/NP 	 1 	 range of
12 	 13 	 (NP[nb]/N)\NP 	 2 	 analysts '
14 	 11 	 (NP\NP)/NP 	 2 	 forecasts of
14 	 13 	 (NP[nb]/N)\NP 	 1 	 forecasts '
<\s>
<s id="wsj_1597.12"> 14
1 	 0 	 NP[nb]/N 	 1 	 scope The
1 	 2 	 (NP\NP)/NP 	 1 	 scope of
1 	 9 	 ((S[dcl]\NP)/PP)/NP 	 1 	 scope caught
4 	 2 	 (NP\NP)/NP 	 2 	 improvement of
4 	 3 	 NP[nb]/N 	 1 	 improvement the
4 	 5 	 (NP\NP)/NP 	 1 	 improvement in
8 	 5 	 (NP\NP)/NP 	 2 	 business in
8 	 6 	 NP[nb]/N 	 1 	 business the
8 	 7 	 N/N 	 1 	 business U.S.
11 	 9 	 ((S[dcl]\NP)/PP)/NP 	 3 	 analysts caught
11 	 10 	 NP[nb]/N 	 1 	 analysts some
12 	 9 	 ((S[dcl]\NP)/PP)/NP 	 2 	 by caught
13 	 12 	 PP/NP 	 1 	 surprise by
<\s>
<s id="wsj_1597.13"> 17
1 	 0 	 NP[nb]/N 	 1 	 company The
1 	 2 	 (NP[nb]/N)\NP 	 2 	 company 's
4 	 2 	 (NP[nb]/N)\NP 	 1 	 business 's
4 	 3 	 N/N 	 1 	 business domestic
4 	 6 	 NP/NP 	 1 	 business especially
4 	 12 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 business has
4 	 13 	 S[pt]\NP 	 1 	 business performed <XB>
10 	 6 	 NP/NP 	 1 	 division especially
10 	 7 	 NP[nb]/N 	 1 	 division its
10 	 8 	 N/N 	 1 	 division household
10 	 9 	 N/N 	 1 	 division products
10 	 12 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 division has
10 	 13 	 S[pt]\NP 	 1 	 division performed <XB>
13 	 12 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 performed has
13 	 14 	 (S\NP)\(S\NP) 	 2 	 performed poorly
13 	 15 	 ((S\NP)\(S\NP))/NP 	 2 	 performed for
16 	 15 	 ((S\NP)\(S\NP))/NP 	 3 	 years for
<\s>
<s id="wsj_1597.14"> 13
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 Analysts say
4 	 2 	 NP[nb]/N 	 1 	 improvement the
4 	 3 	 N/N 	 1 	 improvement earnings
4 	 5 	 S[dcl]\NP 	 1 	 improvement came
4 	 7 	 (S[ng]\NP)/NP 	 1 	 improvement cutting <XB>
4 	 11 	 (S[ng]\NP)/NP 	 1 	 improvement increasing <XU>
5 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 came say
5 	 6 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 came from
7 	 6 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 cutting from
8 	 7 	 (S[ng]\NP)/NP 	 2 	 costs cutting
10 	 9 	 conj/conj 	 1 	 than rather
11 	 6 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 increasing from
12 	 11 	 (S[ng]\NP)/NP 	 2 	 sales increasing
<\s>
<s id="wsj_1597.15"> 19
3 	 0 	 (S/S)/NP 	 2 	 months For
3 	 1 	 NP[nb]/N 	 1 	 months the
3 	 2 	 N/N 	 1 	 months nine
5 	 6 	 S[dcl]\NP 	 1 	 net increased
6 	 0 	 (S/S)/NP 	 1 	 increased For
6 	 8 	 (S\NP)\(S\NP) 	 2 	 increased %
6 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 increased to
8 	 7 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 14
10 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
12 	 10 	 N/N[num] 	 1 	 million $
12 	 11 	 N/N 	 1 	 million 217.5
15 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
15 	 17 	 (NP\NP)/N 	 1 	 $ a
16 	 15 	 N/N[num] 	 1 	 3.09 $
18 	 17 	 (NP\NP)/N 	 2 	 share a
<\s>
<s id="wsj_1597.16"> 8
0 	 1 	 S[dcl]\NP 	 1 	 Sales rose
1 	 3 	 (S\NP)\(S\NP) 	 2 	 rose %
1 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 rose to
3 	 2 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 7
5 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
7 	 5 	 N/N[num] 	 1 	 billion $
7 	 6 	 N/N 	 1 	 billion 3.8
<\s>
<s id="wsj_1597.17"> 17
1 	 0 	 NP[nb]/N 	 1 	 company The
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 company earned
2 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 earned in
3 	 2 	 (S[dcl]\NP)/NP 	 2 	 $ earned
5 	 3 	 N/N[num] 	 1 	 million $
5 	 4 	 N/N 	 1 	 million 191.1
8 	 2 	 (S[dcl]\NP)/NP 	 2 	 $ earned
8 	 10 	 (NP\NP)/N 	 1 	 $ a
9 	 8 	 N/N[num] 	 1 	 2.79 $
11 	 10 	 (NP\NP)/N 	 2 	 share a
16 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 period in
16 	 14 	 NP[nb]/N 	 1 	 period the
16 	 15 	 N/N 	 1 	 period year-earlier
<\s>
<s id="wsj_1597.18"> 19
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Colgate 's
4 	 1 	 (NP[nb]/N)\NP 	 1 	 income 's
4 	 2 	 N/N 	 1 	 income 1988
4 	 3 	 N/N 	 1 	 income net
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 income included
6 	 5 	 (S[dcl]\NP)/NP 	 2 	 $ included
6 	 16 	 (NP\NP)/NP 	 1 	 $ from
8 	 6 	 N/N[num] 	 1 	 million $
8 	 7 	 N/N 	 1 	 million 40.1
12 	 5 	 (S[dcl]\NP)/NP 	 2 	 cents included
12 	 11 	 N/N 	 1 	 cents 59
12 	 13 	 (NP\NP)/N 	 1 	 cents a
12 	 16 	 (NP\NP)/NP 	 1 	 cents from
14 	 13 	 (NP\NP)/N 	 2 	 share a
18 	 16 	 (NP\NP)/NP 	 2 	 operations from
18 	 17 	 N/N 	 1 	 operations discontinued
<\s>
<s id="wsj_1597.19"> 12
0 	 1 	 (S[dcl]\NP)/NP 	 1 	 Colgate sold
1 	 11 	 (S\NP)\(S\NP) 	 2 	 sold year
4 	 1 	 (S[dcl]\NP)/NP 	 2 	 supply sold
4 	 2 	 NP[nb]/N 	 1 	 supply its
4 	 3 	 N/N 	 1 	 supply hospital
9 	 1 	 (S[dcl]\NP)/NP 	 2 	 business sold
9 	 2 	 NP[nb]/N 	 1 	 business its
9 	 3 	 N/N 	 1 	 business hospital
9 	 6 	 N/N 	 1 	 business home
9 	 7 	 N/N 	 1 	 business health
9 	 8 	 N/N 	 1 	 business care
11 	 10 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 year last
<\s>
<s id="wsj_1597.20"> 36
2 	 4 	 (S[dcl]\NP)/NP 	 1 	 Colgate finalized
4 	 0 	 S/S 	 1 	 finalized Separately
4 	 3 	 (S\NP)/(S\NP) 	 2 	 finalized Wednesday
6 	 4 	 (S[dcl]\NP)/NP 	 2 	 agreement finalized
6 	 5 	 NP[nb]/N 	 1 	 agreement an
6 	 7 	 (NP\NP)/NP 	 1 	 agreement with
9 	 7 	 (NP\NP)/NP 	 2 	 Corp. with
9 	 8 	 N/N 	 1 	 Corp. MacroChem
14 	 13 	 (N/N)/(N/N) 	 2 	 products dental
16 	 13 	 (N/N)/(N/N) 	 2 	 pharmaceutical dental
17 	 7 	 (NP\NP)/NP 	 2 	 concern with
17 	 11 	 NP[nb]/N 	 1 	 concern a
17 	 12 	 N/N 	 1 	 concern tiny
17 	 14 	 N/N 	 1 	 concern products <XU>
17 	 16 	 N/N 	 1 	 concern pharmaceutical
17 	 18 	 S[pss]\NP 	 1 	 concern based <XB>
18 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 based in
20 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 Billerica in
22 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 Mass. in
25 	 24 	 (S[to]\NP)/(S[b]\NP) 	 2 	 market to
25 	 26 	 ((S\NP)\(S\NP))/NP 	 2 	 market in
28 	 26 	 ((S\NP)\(S\NP))/NP 	 3 	 U.S. in
28 	 27 	 NP[nb]/N 	 1 	 U.S. the
29 	 25 	 (S[b]\NP)/NP 	 2 	 four market
29 	 30 	 (NP\NP)/NP 	 1 	 four of
31 	 32 	 (NP[nb]/N)\NP 	 2 	 MacroChem 's
35 	 30 	 (NP\NP)/NP 	 2 	 products of
35 	 32 	 (NP[nb]/N)\NP 	 1 	 products 's
35 	 33 	 N/N 	 1 	 products FDA-approved
35 	 34 	 N/N 	 1 	 products dental
<\s>
<s id="wsj_1597.21"> 19
1 	 0 	 NP[nb]/N 	 1 	 products The
1 	 2 	 (NP\NP)/NP 	 1 	 products --
1 	 12 	 (S[dcl]\NP)/NP 	 1 	 products contain
3 	 2 	 (NP\NP)/NP 	 2 	 sealants --
3 	 7 	 S[pss]\NP 	 1 	 sealants used <XB>
6 	 2 	 (NP\NP)/NP 	 2 	 materials --
6 	 5 	 N/N 	 1 	 materials bonding
6 	 7 	 S[pss]\NP 	 1 	 materials used <XB>
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 used by
9 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 dentists by
12 	 11 	 (S\NP)/(S\NP) 	 2 	 contain all
13 	 12 	 (S[dcl]\NP)/NP 	 2 	 fluoride contain
13 	 14 	 (NP\NP)/(S[dcl]\NP) 	 1 	 fluoride that
13 	 15 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 fluoride is <XB>
13 	 16 	 S[pss]\NP 	 1 	 fluoride released <XB>
15 	 14 	 (NP\NP)/(S[dcl]\NP) 	 2 	 is that
16 	 15 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 released is
16 	 17 	 ((S\NP)\(S\NP))/NP 	 2 	 released over
18 	 17 	 ((S\NP)\(S\NP))/NP 	 3 	 time over
<\s>
<s id="wsj_1597.22"> 19
1 	 0 	 NP[nb]/N 	 1 	 move The
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 move is
2 	 18 	 (S[dcl]\S[dcl])\NP 	 1 	 is said
3 	 2 	 (S[dcl]\NP)/NP 	 2 	 part is
3 	 4 	 (NP\NP)/NP 	 1 	 part of
6 	 4 	 (NP\NP)/NP 	 2 	 drive of
6 	 5 	 NP[nb]/N 	 1 	 drive a
8 	 7 	 (S[to]\NP)/(S[b]\NP) 	 2 	 increase to
9 	 10 	 (NP[nb]/N)\NP 	 2 	 Colgate 's
11 	 8 	 (S[b]\NP)/NP 	 2 	 business increase
11 	 10 	 (NP[nb]/N)\NP 	 1 	 business 's
11 	 12 	 (NP\NP)/NP 	 1 	 business with
13 	 12 	 (NP\NP)/NP 	 2 	 dentists with
17 	 15 	 NP[nb]/N 	 1 	 spokeswoman a
17 	 16 	 N/N 	 1 	 spokeswoman company
17 	 18 	 (S[dcl]\S[dcl])\NP 	 2 	 spokeswoman said
<\s>
<s id="wsj_1597.23"> 7
0 	 1 	 (NP\NP)/NP 	 1 	 Terms of
0 	 4 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 Terms were
0 	 6 	 S[pss]\NP 	 1 	 Terms given <XB>
3 	 1 	 (NP\NP)/NP 	 2 	 agreement of
3 	 2 	 NP[nb]/N 	 1 	 agreement the
4 	 5 	 (S\NP)\(S\NP) 	 2 	 were n't
6 	 4 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 given were
<\s>
